Ignite Creation Date:
2024-05-05 @ 7:43 PM
Last Modification Date:
2024-10-26 @ 9:53 AM
Study NCT ID:
NCT00729911
Status:
COMPLETED
Last Update Posted:
2019-04-10
First Post:
2008-08-06
Brief Title:
Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD
Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Organization:
Texas Cardiac Arrhythmia Research Foundation
Study Overview
Official Title:
Ablation vs Amiodarone for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted ICDCRTD
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
1 To determine if catheter-based atrial fibrillation AF ablation is superior to Amiodarone treatment for symptomatic persistentpermanent AF in ICDCRTD patients with an impaired left ventricular function
2 Hypothesis AF ablation is better than Amiodarone for subjects with symptomatic persistent or permanent AF and impaired LV function in terms of recurrence of AF quality of life 6-minute walk distance EF and total number of hospitalizations
2 Hypothesis AF ablation is better than Amiodarone for subjects with symptomatic persistent or permanent AF and impaired LV function in terms of recurrence of AF quality of life 6-minute walk distance EF and total number of hospitalizations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None